|
1
|
Corté H, Manceau G, Blons H and
Laurent-Puig P: MicroRNA and colorectal cancer. Dig Liver Dis.
44:195–200. 2012.
|
|
2
|
Boyle P and Levin B: Colorectal cancer.
World Cancer Report 2008. IARC Press; Lyon: pp. 374–378. 2008
|
|
3
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in Human Cancer. Adv Exp Med Biol. 774:1–20. 2013.
View Article : Google Scholar
|
|
4
|
Zhu W, Liu X, He J, Chen D, Hunag Y and
Zhang YK: Overexpression of members of the microRNA-183 family is a
risk factor for lung cancer: a case control study. BMC Cancer.
11:3932011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Noonan EJ, Place RF, Pookot D, Basak S,
Whitson JM, Hirata H, Giardina C and Dahiya R: miR-449a targets
HDAC-1 and induces growth arrest in prostate cancer. Oncogene.
28:1714–1724. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Noonan EJ, Place RF, Basak S, Pookot D and
Li LC: miR-449a causes Rb-dependent cell cycle arrest and
senescence in prostate cancer cells. Oncotarget. 1:349–358.
2010.PubMed/NCBI
|
|
7
|
Jeon HS, Lee SY, Lee EJ, Yun SC, Cha EJ,
Choi E, Na MJ, Park JY, Kang J and Son JW: Combining
microRNA-449a/b with a HDAC inhibitor has a synergistic effect on
growth arrest in lung cancer. Lung Cancer. 76:171–176. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Buurman R, Gürlevik E, Schäffer V, Eilers
M, Sandbothe M, Kreipe H, Wilkens L, Schlegelberger B, Kühnel F and
Skawran B: Histone deacetylases activate hepatocyte growth factor
signaling by repressing microRNA-449 in hepatocellular carcinoma
cells. Gastroenterology. 143:811–820. 2012. View Article : Google Scholar
|
|
9
|
Bou Kheir T, Futoma-Kazmierczak E,
Jacobsen A, Krogh A, Bardram L, Hother C, Grønbæk K, Federspiel B,
Lund AH and Friis-Hansen L: miR-449 inhibits cell proliferation and
is down-regulated in gastric cancer. Mol Cancer.
18;10:292011.PubMed/NCBI
|
|
10
|
Zhang Q, He XJ, Ma LP, Li N, Yang J, Cheng
YX and Cui H: Expression and significance of microRNAs in the p53
pathway in ovarian cancer cells and serous ovarian cancer tissues.
Zhonghua Zhong Liu Za Zhi. 33:885–890. 2011.(In Chinese).
|
|
11
|
Yang X, Feng M, Jiang X, Wu Z, Li Z, Aau M
and Yu Q: miR-449a and miR-449b are direct transcriptional targets
of E2F1 and negatively regulate pRb-E2F1 activity through a
feedback loop by targeting CDK6 and CDC25A. Genes Dev.
23:2388–2393. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen H, Lin YW, Mao YQ, Wu J, Liu YF,
Zheng XY and Xie LP: MicroRNA-449a acts as a tumor suppressor in
human bladder cancer through the regulation of pocket proteins.
Cancer Lett. 320:40–47. 2012. View Article : Google Scholar
|
|
13
|
Lizé M, Pilarski S and Dobbelstein M:
E2F1-inducible microRNA 449a/b suppresses cell proliferation and
promotes apoptosis. Cell Death Differ. 17:452–458. 2010.PubMed/NCBI
|
|
14
|
Guo C, Sah JF, Beard L, Willson JK,
Markowitz SD and Guda K: The noncoding RNA, miR-126, suppresses the
growth of neoplastic cells by targeting phosphatidylinositol
3-kinase signaling and is frequently lost in colon cancers. Genes
Chromosomes Cancer. 47:939–946. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lardizábal MN, Nocito AL, Daniele SM,
Ornella LA, Palatnik JF and Veggi LM: Reference genes for real-time
PCR quantification of microRNAs and messenger RNAs in rat models of
hepatotoxicity. PLoS One. 7:e363232012.PubMed/NCBI
|
|
16
|
Liu M, Tang Q, Qiu M, Lang N, Li M, Zheng
Y and Bi F: miR-21 targets the tumor suppressor RhoB and regulates
proliferation, invasion and apoptosis in colorectal cancer cells.
FEBS Lett. 585:2998–3005. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Watahiki A and Wang Y, Morris J, Dennis K,
O’Dwyer HM, Gleave M, Gout PW and Wang Y: MicroRNAs associated with
metastatic prostate cancer. PLoS One. 6:e249502011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mihelich BL, Khramtsova EA, Arva N,
Vaishnav A, Johnson DN, Giangreco AA, Martens-Uzunova E, Bagasra O,
Kajdacsy-Balla A and Nonn L: miR-183-96-182 cluster is
overexpressed in prostate tissue and regulates zinc homeostasis in
prostate cells. J Biol Chem. 286:44503–44511. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu S, Lu Z, Liu C, Meng Y, Ma Y, Zhao W,
Liu J, Yu J and Chen J: miRNA-96 suppresses KRAS and functions as a
tumor suppressor gene in pancreatic cancer. Cancer Res.
70:6015–6025. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Boras Z, Kondza G, Sisljagić V, Busić Z,
Gmajnić R and Istvanić T: Prognostic factors of local recurrence
and survival after curative rectal cancer surgery: a single
institution experience. Coll Antropol. 36:1355–1361. 2012.
|
|
21
|
Meimarakis G, Angele M, Conrad C, Schauer
R, Weidenhagen R, Crispin A, Giessen C, Preissler G, Wiedemann M,
Jauch KW, et al: Combined resection of colorectal hepatic-pulmonary
metastases shows improved outcome over chemotherapy alone.
Langenbecks Arch Surg. 398:265–276. 2013. View Article : Google Scholar
|
